Metoprolol

Your heart has receptors called beta-1 adrenergic receptors that respond to adrenaline (epinephrine) and noradrenaline (norepinephrine) ^{[1, 2]}. When these receptors are activated — such as during stress, exercise, or the "fight-or-flight" response — your heart beats faster and harder, and your blood pressure rises. Metoprolol selectively blocks these beta-1 receptors, producing several cardiovascular effects ^{[1, 3]}.

By blocking beta-1 receptors, metoprolol slows your heart rate (negative chronotropy), reduces the force of heart contractions (negative inotropy), and lowers blood pressure by reducing cardiac output and suppressing renin release from the kidneys ^{[1, 3]}. The net effect is that your heart works less hard and requires less oxygen — which is why metoprolol helps prevent angina (chest pain from insufficient oxygen to the heart) and protects the heart after a heart attack ^{[1, 4]}.

In heart failure, the benefits of metoprolol are paradoxical but well-proven ^{[1, 5]}. While one might expect that reducing heart contractility would worsen heart failure, the opposite occurs with careful, gradual introduction. By blocking the chronic overstimulation of the sympathetic nervous system that drives heart failure progression, metoprolol allows the heart to remodel and recover function over months. The landmark MERIT-HF trial demonstrated a 34% reduction in all-cause mortality in patients with heart failure treated with extended-release metoprolol ^[5].

Metoprolol is described as cardioselective because at therapeutic doses, it preferentially blocks cardiac beta-1 receptors over pulmonary and vascular beta-2 receptors ^[1]. This selectivity — though not absolute at higher doses — makes it safer for patients with mild asthma or COPD compared to non-selective beta-blockers like propranolol ^{[1, 3]}.

Days 1-7 (initiation) [1, 2]: Heart rate begins to slow, typically by 10-20 bpm from baseline ^[1]. Blood pressure starts to decrease. You may feel slightly tired, fatigued, or lightheaded during the first week as your body adjusts to the lower heart rate and blood pressure. These symptoms are usually mild and transient.

Weeks 2-4 (dose optimization): Blood pressure reduction becomes more consistent ^{[1, 3]}. Resting heart rate stabilizes at the new lower level. Initial fatigue often improves. Cold hands and feet may occur due to reduced peripheral blood flow (more common with higher doses or non-selective beta-blockers). Your doctor may gradually increase the dose based on blood pressure and heart rate response.

Months 1-3 (established therapy): Full blood pressure-lowering benefit is achieved ^[1]. For heart failure, improvement may take 3-6 months as the heart gradually remodels ^[5]. Do not expect immediate improvement in heart failure symptoms — in fact, some patients experience a transient worsening of heart failure symptoms during the initiation phase, which is why doses are increased very slowly in heart failure (doubling every 2 weeks) ^{[1, 5]}.

Common side effects [1, 2]: Fatigue (approximately 10%), dizziness (approximately 10%), diarrhea, depression, shortness of breath (rare at cardioselective doses), and sexual dysfunction (less common than with non-selective beta-blockers). Bradycardia (heart rate below 50 bpm) may occur and should be reported to your doctor ^{[1, 4]}.

Ongoing monitoring: Long-term cardiovascular protection is maintained with continued use ^{[1, 3, 5]}. Regular monitoring of heart rate and blood pressure is important. Metoprolol is typically a lifelong medication for established cardiovascular indications.

Food — formulation-specific [1, 2]: - Metoprolol tartrate (immediate-release): Should be taken with food or immediately after meals to enhance absorption ^[1]. Food increases bioavailability by approximately 40%. - Metoprolol succinate (extended-release): Can be taken with or without food, but should be taken consistently (always with food or always without) ^[1]. Do not crush, chew, or split the extended-release tablet — it can be scored and divided only at the score line ^{[1, 2]}.

Alcohol: Alcohol may enhance the blood-pressure-lowering effect of metoprolol, potentially causing excessive hypotension, dizziness, lightheadedness, and fainting ^[1]. Alcohol also has direct negative effects on cardiac function. Moderate your alcohol intake and be cautious about positional changes (standing up quickly) after drinking.

Drug interactions of clinical significance [1, 3]: - CYP2D6 inhibitors (fluoxetine, paroxetine, bupropion, quinidine): Can significantly increase metoprolol levels, leading to excessive bradycardia and hypotension. Dose adjustment may be needed ^{[1, 3]}. - Calcium channel blockers (verapamil, diltiazem): Combined with metoprolol, can cause severe bradycardia, heart block, and heart failure. Use with extreme caution ^[1]. - Clonidine: If both are used, discontinue metoprolol several days before stopping clonidine to prevent rebound hypertension ^[1]. - Digoxin: Additive bradycardic effects. Monitor heart rate closely ^[1]. - Non-selective beta-agonists (epinephrine): In patients on beta-blockers, epinephrine may cause paradoxical hypertension.

Hypertension [1, 2]: - Tartrate (IR): Start 50 mg twice daily. May increase at weekly intervals. Usual dose: 100-200 mg/day in 2 divided doses. Maximum: 450 mg/day. - Succinate (ER): Start 25-100 mg once daily. May increase at weekly intervals. Maximum: 400 mg/day.

Heart failure (metoprolol succinate ER ONLY) [1, 5]: - Start: 12.5-25 mg once daily (NYHA class II-IV with stable baseline therapy) - Double the dose every 2 weeks as tolerated - Target dose: 200 mg once daily - Critical: Do not initiate during acute decompensated heart failure. Patient must be on stable doses of ACE inhibitor/ARB and diuretic first ^{[1, 5]}.

Post-myocardial infarction [1, 4]: - Early phase (tartrate): 50 mg every 6 hours for 48 hours, starting within 24 hours of MI - Maintenance: 100 mg twice daily (tartrate) or 200 mg once daily (succinate)

Angina pectoris [1]: - Tartrate: 50-100 mg twice daily. Maximum: 400 mg/day.

Important warnings [1]: - NEVER stop metoprolol abruptly — taper over 1-2 weeks to avoid rebound tachycardia, worsening angina, and potential MI ^[1] - Metoprolol tartrate and succinate are NOT interchangeable without dose conversion — they have different dosing schedules and release mechanisms ^{[1, 2, 6]}

Available forms [1, 2]: Tartrate tablets (25, 50, 100 mg), succinate ER tablets (25, 50, 100, 200 mg), injection (1 mg/mL for IV use).

Generic metoprolol is widely available in both salt forms (tartrate and succinate) and is one of the most affordable cardiovascular medications ^{[7, 8]}.

Pricing comparison [7, 8]: - Generic metoprolol tartrate: $4-15/month - Generic metoprolol succinate ER: $10-30/month - Brand Lopressor (tartrate): $50-100/month (rarely prescribed) - Brand Toprol-XL (succinate): $100-200/month (rarely prescribed) - Available on $4 generic programs at most major pharmacies

Insurance coverage: Most insurance plans cover both generic metoprolol formulations at the lowest copay tier ($0-10/month) ^{[7, 8]}. The tartrate (IR) formulation is slightly cheaper than the succinate (ER), but the succinate's once-daily dosing may improve adherence.

Cost-saving strategies: Always request generic metoprolol — there is no clinical reason to use brand-name Lopressor or Toprol-XL ^[7]. GoodRx and pharmacy discount programs can further reduce costs to under $10/month. 90-day mail-order supplies offer additional savings.

Important cost note: When comparing tartrate vs. succinate, the total daily dose may differ due to the different release profiles ^{[1, 6]}. Tartrate 50 mg twice daily is not identical to succinate 100 mg once daily — discuss with your provider which formulation is most appropriate for your condition. For heart failure, only the succinate (ER) formulation is FDA-approved based on the MERIT-HF trial data ^{[1, 5]}.

Pregnancy: Metoprolol is generally considered relatively safe during pregnancy when the benefit outweighs the risk ^{[1, 2]}. It was formerly classified as FDA Pregnancy Category C, indicating that animal studies showed some adverse effects but human data are reassuring in most circumstances.

Beta-blockers, including metoprolol, can cause fetal and neonatal effects including bradycardia, hypoglycemia, and intrauterine growth restriction (IUGR) ^{[1, 4]}. These effects are dose-dependent and generally reversible. Among the beta-blockers, metoprolol (along with labetalol) is considered one of the preferred options when a beta-blocker is needed during pregnancy — for example, for chronic hypertension, arrhythmias, or migraine prophylaxis ^{[4, 7]}.

Delivery considerations: Neonates exposed to metoprolol near delivery should be monitored for bradycardia, hypotension, hypoglycemia, and respiratory depression for at least 48-72 hours ^[1].

Breastfeeding: Metoprolol is excreted in breast milk, with the relative infant dose estimated at approximately 1.4% of the weight-adjusted maternal dose ^{[1, 2]}. The American Academy of Pediatrics (AAP) considers metoprolol compatible with breastfeeding ^[7]. However, the infant should be monitored for signs of beta-blockade: bradycardia (slow heart rate), hypoglycemia (poor feeding, lethargy), and hypotension. These effects are rare given the low breast milk exposure.

Bottom line: Metoprolol is among the safer cardiovascular medications during pregnancy and breastfeeding, but monitoring of the infant is warranted ^{[1, 4, 7]}.

Generic metoprolol has been available for many years in both salt forms and is dramatically less expensive than the brand-name products ^{[7, 8]}.

Available generic formulations: - Metoprolol tartrate (immediate-release): 25, 50, 100 mg tablets — generic equivalent to Lopressor - Metoprolol succinate (extended-release): 25, 50, 100, 200 mg tablets — generic equivalent to Toprol-XL - Both are rated as therapeutically equivalent (AB-rated) by the FDA ^[7]

CRITICAL: Tartrate and succinate are NOT interchangeable [1, 2, 6]: This is one of the most important pharmacological distinctions in cardiovascular medicine. Metoprolol tartrate and metoprolol succinate have different: - Release mechanisms (immediate vs. controlled) - Dosing schedules (twice daily vs. once daily) - FDA-approved indications (succinate is the only form approved for heart failure) - Pharmacokinetic profiles (peak-trough fluctuations differ)

Always verify which form is prescribed. Pharmacy substitution between tartrate and succinate should NOT occur — they are different products. If your doctor prescribes "metoprolol," clarify whether tartrate or succinate is intended.

Cost comparison: Generic tartrate ($4-15/month) is slightly cheaper than generic succinate ($10-30/month), but both are extremely affordable ^{[7, 8]}. For hypertension alone, either form is effective. For heart failure, succinate ER is specifically required based on clinical trial evidence ^[5].